APA (7th ed.) Citation

N, G., I, B., A, S., L, v. W., M, W., S, E., . . . T, S. (2025). Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs. Signal transduction and targeted therapy, 10(1), 92. https://doi.org/10.1038/s41392-025-02180-4

Chicago Style (17th ed.) Citation

N, Gremke, et al. "Targeting PI3K Inhibitor Resistance in Breast Cancer with Metabolic Drugs." Signal Transduction and Targeted Therapy 10, no. 1 (2025): 92. https://doi.org/10.1038/s41392-025-02180-4.

MLA (9th ed.) Citation

N, Gremke, et al. "Targeting PI3K Inhibitor Resistance in Breast Cancer with Metabolic Drugs." Signal Transduction and Targeted Therapy, vol. 10, no. 1, 2025, p. 92, https://doi.org/10.1038/s41392-025-02180-4.